共 50 条
- [31] Frontline docetaxel (T) capecitabine M combination therapy in patients (pts) with metastatic breast cancer (MBC): A phase II study.JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 71S - 71SChun, JHLee, HGLee, ESKim, EOh, JHRo, J
- [32] Concurrent whole brain radiotherapy (WBRT) and trastuzumab (T) in breast cancer (BC) patients presenting with brain metastasesEJC SUPPLEMENTS, 2010, 8 (03): : 87 - 87Riahi, H.Pierga, J. Y.Bollet, M. A.Cottu, P.Campana, F.Dendale, R.Dorval, T.Dieras, V.Fourquet, A.Kirova, Y. M.
- [33] Open-label phase Ib study of entinostat (E), and lapatinib (L) alone, and in combination with trastuzumab (T) in patients (pts) with HER2+metastatic (mHER2+) breast cancer after progression on trastuzumab.JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)Lim, BoraMurthy, Rashmi KrishnaJackson, SummerWilley, Jie S.Lee, JangsoonAlvarez, Ricardo H.Barcenas, Carlos HernandoKaruturi, Meghan SriIbrahim, Nuhad K.Booser, Daniel J.Moulder, Stacy L.Giordano, Sharon HermesBrewster, Abenaa M.Walters, Ronald StewartBrown, PowelTripathy, DebuValero, VicenteUeno, Naoto T.
- [34] EGF105084, a phase II study of lapatinib for brain metastases in patients (pts) with HER2+breast cancer following trastuzumab (H) based systemic therapy and cranial radiotherapy (RT)JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)Lin, N. U.Dieras, V.Paul, D.Lossignol, D.Christodoulou, C.Laessig, D.Roche, H.Zembryki, D.Oliva, C. R.Winer, E. P.
- [35] Nivolumab in combination with cabozantinib for metastatic triple-negative breast cancer: a phase II and biomarker studyNPJ BREAST CANCER, 2021, 7 (01)Barroso-Sousa, RomualdoKeenan, Tanya E.Li, TianyuTayob, NabihahTrippa, LorenzoPastorello, Ricardo G.Richardson, Edward T., IIIDillon, DeborahAmoozgar, ZohrehOvermoyer, BethSchnitt, Stuart J.Winer, Eric P.Mittendorf, Elizabeth A.Van Allen, EliezerDuda, Dan G.Tolaney, Sara M.
- [36] Nivolumab in combination with cabozantinib for metastatic triple-negative breast cancer: a phase II and biomarker studynpj Breast Cancer, 7Romualdo Barroso-SousaTanya E. KeenanTianyu LiNabihah TayobLorenzo TrippaRicardo G. PastorelloEdward T. Richardson IIIDeborah DillonZohreh AmoozgarBeth OvermoyerStuart J. SchnittEric P. WinerElizabeth A. MittendorfEliezer Van AllenDan G. DudaSara M. Tolaney
- [37] A phase II study of nivolumab in combination with cabozantinib for metastatic triple-negative breast cancer (mTNBC).JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)Barroso-Sousa, RomualdoGuo, HaoBarry, William ThomasWinship, GraceOvermoyer, BethDuda, Dan G.Tolaney, Sara M.
- [38] Phase II trial of carboplatin and bevacizumab in patients with breast cancer brain metastasesBreast Cancer Research, 22Jose Pablo LeoneKyrre E. EmblemMichelle WeitzRebecca S. GelmanBryan P. SchneiderRachel A. FreedmanJerry YoungerMarco C. PinhoA. Gregory SorensenElizabeth R. GerstnerGordon HarrisIan E. KropDaniel MorgansternJessica SohlJiani HuElizabeth KasparianEric P. WinerNancy U. Lin
- [39] Phase II trial of carboplatin and bevacizumab in patients with breast cancer brain metastasesBREAST CANCER RESEARCH, 2020, 22 (01)Leone, Jose PabloEmblem, Kyrre E.Weitz, MichelleGelman, Rebecca S.Schneider, Bryan P.Freedman, Rachel A.Younger, JerryPinho, Marco C.Sorensen, A. GregoryGerstner, Elizabeth R.Harris, GordonKrop, Ian E.Morganstern, DanielSohl, JessicaHu, JianiKasparian, ElizabethWiner, Eric P.Lin, Nancy U.
- [40] Phase II trial of patupilone in patients with brain metastases from breast cancerNEURO-ONCOLOGY, 2014, 16 (04) : 579 - 583Peereboom, David M.Murphy, ConlethAhluwalia, Manmeet S.Conlin, AlisonEichler, AprilVan Poznak, CatherineBaar, JosephElson, PaulSeidman, Andrew D.